THE WELCH COMPANY
440 Davis Court #1602
San Francisco, CA 94111-2496
415 781 5700
rodwelch@pacbell.net


S U M M A R Y


DIARY: May 15, 2008 08:30 AM Thursday; Rod Welch

Millie 3rd treatment 3rd cycle cetuximab Carboplatin 4th relapse IBC.

1...Summary/Objective
...Taxotere Capecitabine 2nd Relapse IBC Treatment After Mastectomy
...Cetuxiab Alone Clinical Study
...Cetuxiab with Carboplatin Clinical Study 2nd Arm
2...Labs Blood Test


..............
Click here to comment!

CONTACTS 

SUBJECTS
Cetuximab 12th Cycle 3rd Treatment 18th Total Treatment Chemotherapy

0403 -
0403 -    ..
0404 - Summary/Objective
0405 -
040501 - Follow up ref SDS 95 0000. ref SDS 94 0000.
040502 -
040503 -
040504 -
040505 -
040506 -
040507 -
040509 -  ..
0406 -
0407 -
0408 - Progress
0409 -
040901 - Background on Millie's treatment in the clinical study is reported on
040902 - 080508. ref SDS 95 TZ8I
040904 -    ..
040905 -   Taxotere Capecitabine 2nd Relapse IBC Treatment After Mastectomy
040906 -
040907 -   Follow up ref SDS 95 XX3O, ref SDS 94 X33O.
040908 -
040909 -   Millie had left mastectomy on 051021.  Biopsy at that time reported
040910 -   no findings of cancer.  Approximately 8 months later on 060707 the
040911 -   doctor diagnosed IBC relapse and prescribed treatment. ref SDS 2
040912 -   PF3O
040913 -
040914 -    1.  Cycle 09 and 01 ................... 060721, ref SDS 3 407N
040915 -    2.  Cycle 10 and 02 ................... 060814, ref SDS 5 LY6O
040916 -    3.  Cycle 11 and 03 ................... 060908, ref SDS 5 407N
040917 -    4.  Cycle 12 and 04 ................... 060929, ref SDS 5 407N
040918 -    5.  Cycle 13 and 05 ................... 061020, ref SDS 6 407N
040919 -    6.  Cycle 14 and 06 ................... 061110, ref SDS 7 407N
040920 -    7.  Cycle 15 and 07 ................... 061201, ref SDS 8 407N
040922 -    ..
040923 -   Cetuxiab Alone Clinical Study
040924 -
040925 -   Follow up ref SDS 95 356I, ref SDS 94 356I.
040926 -
040927 -                   Total    Cetuximab
040928 -    8.  Cycle 01 and 08 and 01 01.......... 070201, ref SDS 10 SG8I
040929 -    9.  Cycle 01 and 08 and 02 02.......... 070208, ref SDS 11 SG8I
040930 -   10.  Cycle 01 and 08 and 03 03.......... 070215, ref SDS 12 SG8I
040931 -   11.  Cycle 01 and 08 and 04 04.......... 070222, ref SDS 13 SG8I
040932 -   12.  Cycle 02 and 09 and 01 05.......... 070301, ref SDS 14 SG8I
040933 -   13.  Cycle 02 and 09 and 02 06.......... 070308, ref SDS 16 7T3H
040934 -   14.  Cycle 02 and 09 and 03 07.......... 070315, ref SDS 17 7T3H
040935 -   15.  Cycle 02 and 09 and 04 08.......... 070322, ref SDS 18 7T3H
040936 -   16.  Cycle 03 and 10 and 01 09.......... 070329, ref SDS 19 7T3H
040937 -   17.  Cycle 03 and 10 and 02 10.......... 070405, ref SDS 20 7T3H
040938 -   18.  Cycle 03 and 10 and 03 11.......... 070412, ref SDS 21 7T3H
040939 -   19.  Cycle 03 and 10 and 04 12.......... 070419, ref SDS 22 7T3H
040940 -   20.  Cycle 04 and 11 and 01 13.......... 070426, ref SDS 23 7T3H
040941 -   21.  Cycle 04 and 11 and 02 14.......... 070503, ref SDS 24 7T3H
040942 -   22.  Cycle 04 and 11 and 03 15.......... 070510, ref SDS 25 7T3H
040943 -   23.  Cycle 04 and 11 and 04 16.......... 070517, ref SDS 26 7T3H
040944 -   24.  Cycle 05 and 12 and 01 17.......... 070524, ref SDS 27 7T3H
040945 -   25.  Cycle 05 and 12 and 02 18.......... 070531, ref SDS 28 7T3H
040946 -   26.  Cycle 05 and 12 and 03 19.......... 070607, ref SDS 29 7T3H
040947 -   27.  Cycle 05 and 12 and 04 20.......... 070614, ref SDS 30 0001
040948 -   28.  Cycle 06 and 13 and 01 21.......... 070621, ref SDS 31 0001
040949 -   29.  Cycle 06 and 13 and 02 22.......... 070628, ref SDS 32 0001
040950 -   30.  Cycle 06 and 13 and 03 23.......... 070705, ref SDS 33 0001
040951 -   31.  Cycle 06 and 13 and 04 24.......... 070712, ref SDS 34 0001
040952 -   32.  Cycle 07 and 14 and 01 25.......... 070719, ref SDS 35 0001
040953 -   33.  Cycle 07 and 14 and 02 26.......... 070726, ref SDS 36 0001
040954 -   34.  Cycle 07 and 14 and 03 27.......... 070802, ref SDS 37 0001
040955 -   35.  Cycle 07 and 14 and 04 28.......... 070809, ref SDS 38 0001
040956 -   36.  Cycle 08 and 15 and 01 29.......... 070816, ref SDS 39 0001
040957 -   37.  Cycle 08 and 15 and 02 30.......... 070823, ref SDS 40 0001
040958 -   38.  Cycle 08 and 15 and 03 31.......... 070830, ref SDS 40 0001
040959 -   39.  Cycle 08 and 15 and 04 32.......... 070906, ref SDS 41 0001
040960 -   40.  Cycle 09 and 16 and 01 33.......... 070920, ref SDS 42 0001
040961 -   41.  Cycle 09 and 16 and 02 34.......... 070927, ref SDS 43 0001
040962 -   42.  Cycle 09 and 16 and 03 35.......... 071004, ref SDS 44 0001
040963 -   43.  Cycle 09 and 16 and 04 36.......... 071011, ref SDS 45 0001
040964 -   44.  Cycle 10 and 17 and 01 37.......... 071018, ref SDS 46 0001
040965 -   45.  Cycle 10 and 17 and 02 38.......... 071025, ref SDS 47 0001
040966 -   46.  Cycle 10 and 17 and 03 39.......... 071101, ref SDS 48 0001
040967 -   47.  Cycle 10 and 17 and 04 40.......... 071108, ref SDS 49 0001
040968 -   48.  Cycle 11 and 18 and 01 41.......... 071115, ref SDS 50 0001
040969 -   49.  Cycle 11 and 18 and 02 42.......... 071122, ref SDS 36 0001
040970 -   50.  Cycle 11 and 18 and 03 43.......... 071129, ref SDS 52 0001
040971 -   51.  Cycle 11 and 18 and 04 44.......... 071206, ref SDS 53 0001
040972 -   52.  Cycle 12 and 19 and 01 45.......... 071213, ref SDS 56 0001
040973 -   53.  Cycle 12 and 19 and 02 46.......... 071220, ref SDS 59 0001
040974 -   54.  Cycle 12 and 19 and 03 47.......... 071227, ref SDS 60 0001
040975 -   55.  Cycle 12 and 19 and 04 48.......... 080103, ref SDS 61 0001
040976 -   56.  Cycle 13 and 20 and 01 49.......... 080110, ref SDS 64 0001
040977 -   57.  Cycle 13 and 20 and 02 50.......... 080117, ref SDS 65 0001
040978 -   58.  Cycle 13 and 20 and 03 51.......... 080124, ref SDS 66 0001
040979 -   59.  Cycle 13 and 20 and 04 52.......... 080131, ref SDS 68 0001
040980 -   60.  Cycle 14 and 21 and 01 53.......... 080207, ref SDS 72 0001
040981 -   61.  Cycle 14 and 21 and 02 54.......... 080214, ref SDS 73 0001
040982 -   62.  Cycle 14 and 21 and 03 55.......... 080221, ref SDS 37 0001
040983 -   63.  Cycle 14 and 21 and 04 56.......... 080228, ref SDS 79 0001
040984 -   64.  Cycle 15 and 22 and 01 57 01  00... 080306, ref SDS 82 TZ8I
040985 -
040987 -    ..
040988 -   Cetuxiab with Carboplatin Clinical Study 2nd Arm
040989 -
040990 -   Follow up ref SDS 95 5B6J, ref SDS 94 5B6J.
040991 -
040992 -   On 080207 doctor reports IBC may be spreading. ref SDS 71 GH5H
040993 -   Follow up examination on 080219 Doctor Rugo diagnosed progression of
040994 -   disease. ref SDS 76 3J4I  Photographs show spread of IBC rash,
040995 -
040996 -             2nd
040997 -             Arm              Cetuximab Carboplatin
040998 -   65.  Cycle 01 15 and 22 and 02 58 02  01... 080313, ref SDS 83 TZ8I
040999 -   66.  Cycle 01 15 and 22 and 03 59 03  01... 080320, ref SDS 84 TZ8I
041000 -   67.  Cycle 01 15 and 22 and 04 60 04  01... 080327, ref SDS 85 TZ8I
041001 -   68.  Cycle 02 16 and 23 and 01 61 05  02... 080403, ref SDS 86 TZ8I
041002 -   69.  Cycle 02 16 and 23 and 02 62 06  03... 080410, ref SDS 89 TZ8I
041003 -   70.  Cycle 02 16 and 23 and 03 63 07  03... 080417, ref SDS 91 TZ8I
041004 -   71.  Cycle 02 16 and 23 and 04 64 08  03... 080424, ref SDS 93 TZ8I
041005 -   72.  Cycle 03 17 and 24 and 01 65 09  04... 080501, ref SDS 94 5B6J
041006 -   73.  Cycle 03 17 and 24 and 02 66 10  05... 080508, ref SDS 95 5B6J
041007 -   74.  Cycle 03 17 and 24 and 03 67 11  05... 080515, ref SDS 0 5B6J
041009 -  ..
041010 - Today is the 3rd treatment of the 3rd cycle with cetuximab and
041011 - Carboplatin together.  This is the 11th treatment overall with
041012 - cetuximab on the 2nd arm of the clinical study, but is only the 5th
041013 - treatment with Carboplatin due to low blood counts, since Millie again
041014 - today did not get Carboplatin because NEUTS are way too low, per
041015 - below. ref SDS 0 PU6K
041016 -
041017 -
041018 -
041019 -
0411 -

SUBJECTS
Default Null Subject Account for Blank Record

0503 -
050401 -  ..
050402 - Labs Blood Test
050403 -
050404 - Follow up ref SDS 95 FW5N, ref SDS 94 FW5N.
050405 -
050406 - Adding Carboplatin to the treatment protocol now requires weekly blood
050407 - tests to determine if the immune system is strong enough for safe
050408 - chemotherapy treatment, reported on 070201, ref SDS 10 XR40, and citing
050409 - the clinical study protocol received from UCSF on 070116. ref SDS 9
050410 - 5U7Z
050412 -  ..
050413 - During treatment, Catherine submitted results of the test.
050414 -
050429 -     ..
050430 -    Log#:                   080403 08:00
050431 -    <----------------------- U C S F -----------------------> <-------------  Kaiser -------------->
050432 -    Type                 Results   Units        Normal        ACRO   Type            Units        Normal
050433 -     ..
050434 -    CBC with DIFF & PLT CT                                     CBCD
050435 -     ..
050436 -    WBC COUNT      L        3.3    x10E9/L     3.4  -   10     WBC   WBC x10-3        K/uL     3.4  -  10.0
050437 -    RBC COUNT               4.09   x10E12/L      4  -   5.2    RBC   RBC x10-6        M/uL    3.60  -  5.70
050438 -    HEMOGLOBIN             13.1    g/dL         12  -   15.5   HGB   Hemoglobin       g/dL    11.5  -  15.0
050439 -    HEMATOCRIT             38.7    PERCENT      36  -   46     HCT   Hematocrit       %       34.0  -  46.0
050440 -    MCV                    94      fL           80  -   100    MCV   MCV              fL      80.0  -  100.0
050441 -    MCH                    32.1    pg           26  -   34     MCH
050442 -    MCHC                   34.0    g/dL         31  -   36     MCHC
050443 -    PLATELETS             248      x10E9/L     140  -  450     PLT   Plt x10-3        K/uL     140  -  400
050444 -
050445 -        Performed at Mt Zion Clinic Lab, 1600 Divisadero, San
050446 -        Francisco, CA  94115
050447 -    ..
050448 -     (NEUTS x 1000 = ANC for Kaiser)
050449 -    NEUTS         L         1.21   x10E9/L     1.8  -  6.8     N-A   ANC                      1500
050450 -    Neutrophils    Not Reported                                      Neutrophils       %        50  -  70
050452 -     ..
050453 -    LYMPHS                  1.63   x10E9/L     0.9  -  2.9     L-A   Lymphocytes       %        20  -  50
050454 -    MONOS                   0.23   x10E9/L     0.1  -  0.6     M-A   Monocyte          %         0  -  11
050455 -    EOS                     0.15   x10E9/L       0  -  0.4     E-A   Esoinophils       %         1  -  5
050456 -    BASOS                   0.06   x10E9/L       0  -  0.1     B-A   Basophil          %         0  -  2
050458 -  ..
050459 - Blood counts fell today with NEUTS 1.21, ref SDS 0 QY6H, compared with
050460 - NEUTS 5.41 last week on 080508, ref SDS 85 QY6H, continues erratic
050461 - history with no evident pattern associated with significantly
050462 - increased exercise.
050464 -  ..
050465 - Megan visited with Millie in the Infusion Clinic.
050467 -  ..
050468 - She initially explained that the doctor has proposed to the Clinical
050469 - Study sponsors deferring treatment today, and Millie come in next
050470 - Tuesday to get Carboplatin.  Millie would then come back on Thursday
050471 - to get cetuximab alone, which is normally the bye week Carboplatin in
050472 - the 4-week cycle of cetuximab.  Megan will check further whether
050473 - Millie should take a Neupogen this week, say tomorrow or Saturday.
050475 -  ..
050476 - The doctor evidently was notified by the Clinical Study sponsors
050477 - recommending that Millie skip Carboplatin entirely this week, as well
050478 - as next week, which is the normal bye week.  This aligns with prior
050479 - practice when Millie has skipped treatments with low blood counts,
050480 - reported on 080320, ref SDS 84 TZ8I, and again on 080417. ref SDS 91
050481 - 0001
050483 -  ..
050484 - Megan advised that Millie will not need to take Neupogen this week
050485 - either, since she is not getting Carboplatin.  May have to start
050486 - taking Neupogen twice per week to maintain blood counts for weekly
050487 - Carboplatin 3 weeks in a row required by the clinical trial protocol.
050488 - So far, Millie has been able to get treatments with Carboplating 2
050489 - weeks a row, even with 1 treatment of Neupogen.
050491 -  ..
050492 - Millie asked for the Chemotherapy Orders issued on 080501 starting the
050493 - cycle, which were not received from UCSF at that time.  The nurse made
050494 - a copy from the medical chart, and gave Millie 2 Chemotherapy Orders,
050495 - which are entered in the record on 080501 showing control of the work.
050496 - ref SDS 94 4E9N
050497 -
050498 -
050499 -
050500 -
050501 -
050502 -
050503 -
050504 -
050505 -
050506 -
0506 -